Detalhe da pesquisa
1.
Analysis of a SARS-CoV-2-Infected Individual Reveals Development of Potent Neutralizing Antibodies with Limited Somatic Mutation.
Immunity
; 53(1): 98-105.e5, 2020 07 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-32561270
2.
Vaccination with nanoparticles displaying gH/gL from Epstein-Barr virus elicits limited cross-protection against rhesus lymphocryptovirus.
Cell Rep Med
; : 101587, 2024 May 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38781964
3.
Structural definition of a pan-sarbecovirus neutralizing epitope on the spike S2 subunit.
Commun Biol
; 5(1): 342, 2022 04 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35411021
4.
Immunization with a self-assembling nanoparticle vaccine displaying EBV gH/gL protects humanized mice against lethal viral challenge.
Cell Rep Med
; 3(6): 100658, 2022 06 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35705092
5.
Development of a VRC01-class germline targeting immunogen derived from anti-idiotypic antibodies.
Cell Rep
; 35(5): 109084, 2021 05 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33951425
6.
A single mRNA immunization boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection.
medRxiv
; 2021 Mar 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33758873
7.
mRNA vaccination boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection.
Science
; 2021 Mar 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-33766944
8.
Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects.
bioRxiv
; 2021 Mar 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-33791692
9.
Designed proteins assemble antibodies into modular nanocages.
Science
; 372(6537)2021 04 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33795432
10.
Isolation and characterization of cross-neutralizing coronavirus antibodies from COVID-19+ subjects.
Cell Rep
; 36(2): 109353, 2021 07 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-34237283
11.
Neutralizing Antibodies Protect against Oral Transmission of Lymphocryptovirus.
Cell Rep Med
; 1(3)2020 06 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-32724901
12.
Characterization of neutralizing antibodies from a SARS-CoV-2 infected individual.
bioRxiv
; 2020 May 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32511342
13.
Designed proteins assemble antibodies into modular nanocages.
bioRxiv
; 2020 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33299994
14.
Development of a VRC01-class germline targeting immunogen derived from anti-idiotypic antibodies.
Cell Rep
; 36(3): 109454, 2021 Jul 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34289363